Molecular Medicine

, Volume 21, Issue 1, pp 197–209 | Cite as

Acetylbritannilactone Modulates MicroRNA-155-Mediated Inflammatory Response in Ischemic Cerebral Tissues

  • Ya Wen
  • Xiangjian Zhang
  • Lipeng Dong
  • Jingru Zhao
  • Cong Zhang
  • Chunhua Zhu
Research Article


Inflammatory responses play a critical role in ischemic brain injury. MicroRNA-155 (miR-155) induces the expression of inflammatory cytokines, and acetylbritannilactone (ABL) exerts potent antiinflammatory actions by inhibiting expression of inflammation-related genes. However, the functions of miR-155 and the actual relationship between ABL and miR-155 in ischemia-induced cerebral inflammation remain unclear. In this study, cerebral ischemia of wild-type (WT) and miR-155−/− mice was induced by permanent middle cerebral artery occlusion (MCAO). pAd-miR-155 was injected into the lateral cerebral ventricle 24 h before MCAO to induce miR-155 overexpression. MCAO mice and oxygen-glucose deprivation (OGD)-treated BV2 cells were used to examine the effects of ABL and miR-155 overexpression or deletion on the expression of proinflammatory cytokines. We demonstrated that ABL treatment significantly reduced neurological deficits and cerebral infarct volume by inhibiting tumor necrosis factor-α (TNF-α) and interleukin-1 β (IL-1 β) expression in ischemic cerebral tissue and OGD-treated BV2 cells. Mechanistic studies suggested that the observed decrease in TNF-α and IL-1 β expression was attributable to the ABL-induced suppression of the expression of nuclear factor-kappa B (NF-κB) and Toll-like receptor 4 (TLR4). We further found that miR-155 promoted TNF-α and IL-1 β expression by upregulating TLR4 and downregulating the expression of suppressor of cytokine signaling 1 (SOCS1) and myeloid differentiation primary response gene 88 (MyD88), while ABL exerted an inhibitory effect on miR-155-mediated gene expression. In conclusion, miR-155 mediates inflammatory responses in ischemic cerebral tissue by modulating TLR4/MyD88 and SOCS1 expression, and ABL exerts its antiinflam-matory action by suppressing miR-155 expression, suggesting a novel miR-155-based therapy for ischemic stroke.



We thank Bin Zheng and Xinhua Zhang (Department of Biochemistry, Hebei Medical University) for their technical assistance. This work was supported by the National Natural Science Foundation of PR China (grant no. 81371287). DISCLOSURE

The authors declare they have no competing interests as defined by Molecular Medicine, or other interests that might be perceived to influence the results and discussion reported in this paper.

Supplementary material

10020_2015_2101197_MOESM1_ESM.pdf (482 kb)
Supplementary material, approximately 482 KB.


  1. 1.
    Macrez R, et al. (2011) Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 10:471–80.CrossRefGoogle Scholar
  2. 2.
    Iadecola C, Anrather J. (2011) The immunology of stroke: from mechanisms to translation. Nat. Med. 17:796–808.CrossRefGoogle Scholar
  3. 3.
    Jin R, Yang G, Li G. (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol. 87:779–89.CrossRefGoogle Scholar
  4. 4.
    Morganti-Kossman MC, et al. (1997) Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry. 2:133–6.CrossRefGoogle Scholar
  5. 5.
    Blohmke CJ, et al. (2010) TLR5 as an antiinflammatory target and modifier gene in cystic fibrosis. J. Immunol. 185:7731–8.CrossRefGoogle Scholar
  6. 6.
    Bsibsi M, Ravid R, Gveric D, van Noort JM. (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013–21.CrossRefGoogle Scholar
  7. 7.
    Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. (1997) MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:837–47.CrossRefGoogle Scholar
  8. 8.
    Yang Y, et al. (2007) Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5–8F via NF-κB and MAPKs signaling pathways. Mol. Immunol. 44:984–92.CrossRefGoogle Scholar
  9. 9.
    Takeda K, Akira S. (2004) TLR signaling pathways. Semin. Immunol. 16:3–9.CrossRefGoogle Scholar
  10. 10.
    Xiao C, Rajewsky K. (2009) MicroRNA control in the immune system: basic principles. Cell. 136:26–36.CrossRefGoogle Scholar
  11. 11.
    O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D. (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 10:111–22.CrossRefGoogle Scholar
  12. 12.
    Ouyang YB, Stary CM, Yang GY, Giffard R. (2013) microRNAs: innovative targets for cerebral ischemia and stroke. Curr. Drug Targets. 14:90–101.CrossRefGoogle Scholar
  13. 13.
    Nazari-Jahantigh M, et al. (2012) MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 122:4190–202.CrossRefGoogle Scholar
  14. 14.
    Hunsberger JG, Fessler EB, Wang Z, Elkahloun AG, Chuang DM. (2012) Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am. J. Transl. Res. 4:316–32.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Li T, et al. (2010) MicroRNAs modulate the non-canonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 11:799–805.CrossRefGoogle Scholar
  16. 16.
    Androulidaki A, et al. (2009) The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 31:220–31.CrossRefGoogle Scholar
  17. 17.
    Ceppi M, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 106:2735–40.CrossRefGoogle Scholar
  18. 18.
    Whan Han J, et al. (2001) Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB. Br. J. Pharmacol. 133:503–12.CrossRefGoogle Scholar
  19. 19.
    Han M, Wen JK, Zheng B, Zhang DQ. (2004) Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sci. 75:675–84.CrossRefGoogle Scholar
  20. 20.
    Liu YP, Wen JK, Zheng B, Zhang DQ, Han M. (2007) Acetylbritannilactone suppresses lipopolysaccharide-induced vascular smooth muscle cell inflammatory response. Eur. J. Pharmacol. 577:28–34.CrossRefGoogle Scholar
  21. 21.
    Liu B, Han M, Wen JK. (2008) Acetylbritannilactone inhibits neointimal hyperplasia after balloon injury of rat artery by suppressing nuclear factor-κB activation. J. Pharmacol. Exp. Ther. 324:292–8.CrossRefGoogle Scholar
  22. 22.
    Liu B, et al. (2011) Acetylbritannilactone induces G1 arrest and apoptosis in vascular smooth muscle cells. Int. J. Cardiol. 149:30–8.CrossRefGoogle Scholar
  23. 23.
    Yang C, Zhang X, Fan H, Liu Y. (2009) Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res. 1282:133–41.CrossRefGoogle Scholar
  24. 24.
    Simonyi A, et al. (2005) Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol. Neurobiol. 31:135–47.CrossRefGoogle Scholar
  25. 25.
    Kreutzberg GW. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312–8.CrossRefGoogle Scholar
  26. 26.
    Olson JK, Miller SD. (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173:3916–24.CrossRefGoogle Scholar
  27. 27.
    Meng Z, Yan Z, Deng Q, Gao DF, Niu XL. (2013) Curcumin inhibits LPS-induced inflammation in 209 rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol. Sin. 34:901–11.CrossRefGoogle Scholar
  28. 28.
    Laird MH, et al. (2009) TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J. Leukoc. Biol. 85:966–77.CrossRefGoogle Scholar
  29. 29.
    Wang Q, Tang XN, Yenari MA. (2007) The inflammatory response in stroke. J. Neuroimmunol. 184:53–68.CrossRefGoogle Scholar
  30. 30.
    Kariko K, Weissman D, Welsh FA. (2004) Inhibition of toll-like receptor and cytokine signaling—a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24:1288–304.CrossRefGoogle Scholar
  31. 31.
    Khan MM, et al. (2012) Alternatively-spliced extra domain A of fibronectin promotes acute inflammation and brain injury after cerebral ischemia in mice. Stroke. 43:1376–82.CrossRefGoogle Scholar
  32. 32.
    Simard AR, Rivest S. (2007) Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 504:716–29.CrossRefGoogle Scholar
  33. 33.
    Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. (2011) Physiology of microglia. Physiol. Rev. 91:461–553.CrossRefGoogle Scholar
  34. 34.
    Davies CA, et al. (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19:87–98.CrossRefGoogle Scholar
  35. 35.
    Medzhitov R. (2001) Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135–45.CrossRefGoogle Scholar
  36. 36.
    Yamamoto M, et al. (2002) Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420:324–9.CrossRefGoogle Scholar
  37. 37.
    Fitzgerald KA, et al. (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:78–83.CrossRefGoogle Scholar
  38. 38.
    Kawai T, Akira S. (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13:460–9.CrossRefGoogle Scholar
  39. 39.
    Nakagawa R, et al. (2002) SOCS-1 participates in negative regulation of LPS responses. Immunity. 17:677–87.CrossRefGoogle Scholar
  40. 40.
    Rink C, Khanna S. (2011) MicroRNA in ischemic stroke etiology and pathology. Physiol Genomics. 43:521–8.CrossRefGoogle Scholar
  41. 41.
    Yin KJ, et al. (2010) Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci. 30:6398–408.CrossRefGoogle Scholar
  42. 42.
    Yin KJ, et al. (2010) miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 38:17–26.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2015

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (

Authors and Affiliations

  • Ya Wen
    • 1
    • 2
    • 3
  • Xiangjian Zhang
    • 1
    • 2
    • 3
  • Lipeng Dong
    • 1
    • 2
  • Jingru Zhao
    • 1
    • 2
  • Cong Zhang
    • 1
    • 2
  • Chunhua Zhu
    • 1
    • 2
    • 3
  1. 1.Department of NeurologySecond Hospital of Hebei Medical UniversityShijiazhuang, HebeiPR China
  2. 2.Hebei Key Laboratory for NeurologyShijiazhuang, HebeiPR China
  3. 3.Hebei Collaborative Innovation Center for Cardio-cerebrovascular DiseaseShijiazhuang, HebeiPR China

Personalised recommendations